HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988.
HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988.
复制标题
1987-1988 年斯德哥尔摩静脉吸毒者的艾滋病毒状况和危险行为变化。
DOI：
10.1097/00002030-199002000-00009
复制
发表时间：
1990
期刊：
影响因子：
3.8
通讯作者：
Robert G. Olin
中科院分区：
文献类型：
--
作者：
Kerstin Käll;Robert G. Olin
瑞典斯德哥尔摩还押监狱正在进行一项始于1987年1月的艾滋病毒研究，以跟踪斯德哥尔摩静脉注射吸毒者中的艾滋病毒血清阳性率和艾滋病毒危险行为。截至1988年12月，对1 152名被捕和被拘留的静脉吸毒者进行了有关危险行为的面谈，并进行了艾滋病毒抗体测试。安非他明是斯德哥尔摩静脉注射使用的主要静脉药物，其中958人使用安非他明，194人使用海洛因。HIV血清阳性率为12.6%，其中安非他明组为5.9%，海洛因组为45.5%。据计算，1987年艾滋病毒感染率为0.9%，1988年为1.2%，安非他明使用者高于海洛因使用者。据报告，共用针头的风险有所降低，但性行为的风险降低较少。
An HIV study initiated in January 1987 is being conducted at the Remand Prison in Stockholm, Sweden, in order to follow HIV seroprevalence and HIV risk behaviour among intravenous drug users (IVDUs) in Stockholm. Up to December 1988 1152 arrested and detained IVDUs were interviewed about risk behaviour and tested for HIV antibodies. Amphetamine, which is the main IVDUs drug used intravenously in Stockholm, was used by 958 of these, while heroin was used by 194. HIV seroprevalence was 12.6%: 5.9% among the amphetamine and 45.5% among the heroin users. The HIV incidence was calculated to be 0.9% in 1987 and 1.2% in 1988, higher for amphetamine than for heroin users. Some risk reduction was reported regarding needle sharing, but less so regarding sexual behaviour.